Zimmer Biomet Holdings (XSWX:ZBH) Common Stock: CHF3 Mil (As of Mar. 2026)


XSWX:ZBH Zimmer Biomet Holdings Inc XSWX:ZBH
69 GF Score
Price CHF69.50
GF Value CHF104.19
Valuation Significantly Undervalued
! 3 Warning Signs
View Full Analysis

What is Zimmer Biomet Holdings Common Stock?

Zimmer Biomet Holdings XSWX:ZBH 69 Common Stock is CHF3 Mil as of Mar. 2026. GuruFocus rates XSWX:ZBH with a GF Score™ of 69/100 and a GF Value™ of CHF104.19 (Significantly Undervalued). The stock has 3 warning signs investors should review.

Zimmer Biomet Holdings's quarterly common stock increased from Sep. 2025 (CHF3 Mil) to Dec. 2025 (CHF3 Mil) but then declined from Dec. 2025 (CHF3 Mil) to Mar. 2026 (CHF3 Mil).

Zimmer Biomet Holdings's annual common stock increased from Dec. 2023 (CHF3 Mil) to Dec. 2024 (CHF3 Mil) but then declined from Dec. 2024 (CHF3 Mil) to Dec. 2025 (CHF3 Mil).

Zimmer Biomet Holdings Common Stock Historical Data

* Premium members only.

The historical data trend for Zimmer Biomet Holdings's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Zimmer Biomet Holdings Common Stock Chart

Zimmer Biomet Holdings Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Common Stock
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.86 2.89 2.77 2.85 2.55

Zimmer Biomet Holdings Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Common Stock Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.83 2.60 2.55 2.55 2.52
XSWX:ZBH
69GF Score
Zimmer Biomet Holdings Inc XSWX:ZBH
Common Stock is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Zimmer Biomet Holdings Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.

Frequently Asked Questions Learn more about Common Stock →
What does a Common Stock of CHF3 Mil mean?
Zimmer Biomet Holdings (XSWX:ZBH) has a Common Stock of CHF3 Mil as of Mar. 2026. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on Zimmer Biomet Holdings and its competitors.
Is Zimmer Biomet Holdings' Common Stock too high?
Zimmer Biomet Holdings' current Common Stock is CHF3 Mil. Overall, Zimmer Biomet Holdings has a GF Score™ of 69/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Zimmer Biomet Holdings' Common Stock compare to STE and PEN?
Zimmer Biomet Holdings' Common Stock of CHF3 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Common Stock for a Medical Devices & Instruments company?
A good Common Stock depends on the Medical Devices & Instruments industry context. However, Common Stock should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Common Stock mean?
A high Common Stock can signal that a stock is expensive relative to its fundamentals. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on Zimmer Biomet Holdings and its competitors. Zimmer Biomet Holdings's current Common Stock is CHF3 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Zimmer Biomet Holdings stock overvalued right now?
Based on GuruFocus' analysis, Zimmer Biomet Holdings (XSWX:ZBH) is currently considered Significantly Undervalued. The stock's GF Value™ is CHF104.19, compared to a current price of CHF69.50 — trading 33.3% below its estimated fair value. The current Common Stock is CHF3 Mil. Zimmer Biomet Holdings' overall GF Score™ is 69/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Common Stock calculated?
Common Stock is calculated from a company's financial statements. For Zimmer Biomet Holdings (XSWX:ZBH), the current Common Stock is CHF3 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Zimmer Biomet Holdings (XSWX:ZBH) Overvalued in 2026?

Based on GuruFocus' analysis, Zimmer Biomet Holdings stock appears to be undervalued. The current stock price of CHF69.50 is trading 33.3% below its estimated GF Value™ of CHF104.19. GuruFocus considers Zimmer Biomet Holdings to be Significantly Undervalued.

Key valuation signals for XSWX:ZBH:

  • Common Stock: CHF3 Mil
  • GF Value™: CHF104.19 vs. price of CHF69.50 (33.3% below fair value)
  • GF Score™: 69/100 with 3 warning signs

No single metric tells the full story. See the XSWX:ZBH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Zimmer Biomet Holdings Business Description

Address 345 East Main Street, Warsaw, IN, USA, 46580
Zimmer Biomet designs, manufactures, and markets orthopedic reconstructive implants as well as supplies and surgical equipment for orthopedic surgery. With the acquisitions of Centerpulse in 2003 and Biomet in 2015, Zimmer holds the leading share of the reconstructive market in the United States, Europe, and Japan. Roughly two-thirds of total revenue is derived from sales of large joints; another fourth comes from extremities, trauma, sports medicine, and related surgical products. The firm spun out its dental and spine businesses in 2022.
69GF Score

Get the complete analysis for XSWX:ZBH

Common Stock is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

CHF69.50
Price
CHF104.19
GF Value